Table 6.
Details of cases with hemorrhagic complications
| Age | Intraoperative blood loss (ml) | NS | LND | Details of AC | Perioperative treatment of ACs | Resume of AC | Date of bleeding event | Detail of event | Clavien-Dindo classification | Treatment | Re-resume of AC | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case1 | 73 | 300 | One side | None | Warfarin | Heparinization | POD3 | POD4 | Pelvic hematoma | Grade2 | AC interruption | POD6 |
| Case2 | 73 | 200 | None | None | Dabigatran | Interruption | POD2 | POD21 | Gross hematuria | Grade1 | Continuation | |
| Case3 | 68 | 100 | None | None | Warfarin | Interruption | POD2 | POD19 | Gross hematuria, urinary retention | Grade1 | Continuation | |
| Case4 | 72 | 100 | None | None | Rivaroxaban | Heparinization | POD2 | POD3 | Progression of anemia | Grade1 | AC interruption | POD6 |
NS nerve sparing, LND lymph node dissection, AC anticoagulant